I suspect he may have some hidden conflicts of interest. He isn't very convincing when he is on the wrong side but he has a large following and some of his followers seem to believe everything he says
Having spent 11 years in the cannabinoid space, attending and speaking at ICRS and organizing CannMed, His cannabinoid schizophrenia book is full of holes. He overly relies on NIDA data which is about as trustworthy as CDC data in the pandemic. Now that he has seen how the government science sausage is made, you would hope he would revisit his bias for trusting these same agencies on cannabis... but alas, there is no self reflection and learning with Alex. Just book revenue he doesn't want to admit to being based on untrustworthy propaganda. 5 years of CannMed presentations- live and for free to counter Berenson blow hards. https://cannmedevents.com/cannmed-video-archives/
I gave up pot almost 50 years ago. Made me laugh and hungry and then sleepy. Had to give it up in college though because after doing my homework I’d smoke a joint and next morning forgot everything I learned the night before. Messed up my short term memory. Others seemed fine.
I saw more psycho behavior after folks who were drinking than getting high. If anything the pot blunted this behavior in those who did both. But thats just observation.
THC is just one of ~150 cannabinoids in the plant and prohibition led to a genetic bottleneck for High THC chemotypes as cannabis was prosecuted on weight. 20% THC lines were bred that had 100x lower concentration of the alternative cannabinoids. This came at the expense of selection against the other cannabinoids as they all compete for the same precursors.
This is really evident now that the genomic architecture of the cannabinoid synthases have all been charted out.
The 2018 farm bill enabled genome directed breeding and the field has now bread CBD dominant chemotypes, CBG, CBDV, and THCV, so we are just getting these compounds in economical quantities for experimentation in many neuroinflammation based etiologies.
Some of these chemotypes were also bred prior to the with HPLC directed breeding but they are now getting enhanced with triploids and a variety of tools that were harder to industrialize prior to the change on legislation.
There are many interesting compounds for inflammation, IL-6 suppression and SEB/MISC recovery.
Google THC and SEB , you’ll find many papers from Mohammad et al.
He seems Schizophrenic. Maybe he should try some weed.
I suspect he may have some hidden conflicts of interest. He isn't very convincing when he is on the wrong side but he has a large following and some of his followers seem to believe everything he says
Having spent 11 years in the cannabinoid space, attending and speaking at ICRS and organizing CannMed, His cannabinoid schizophrenia book is full of holes. He overly relies on NIDA data which is about as trustworthy as CDC data in the pandemic. Now that he has seen how the government science sausage is made, you would hope he would revisit his bias for trusting these same agencies on cannabis... but alas, there is no self reflection and learning with Alex. Just book revenue he doesn't want to admit to being based on untrustworthy propaganda. 5 years of CannMed presentations- live and for free to counter Berenson blow hards. https://cannmedevents.com/cannmed-video-archives/
I gave up pot almost 50 years ago. Made me laugh and hungry and then sleepy. Had to give it up in college though because after doing my homework I’d smoke a joint and next morning forgot everything I learned the night before. Messed up my short term memory. Others seemed fine.
I saw more psycho behavior after folks who were drinking than getting high. If anything the pot blunted this behavior in those who did both. But thats just observation.
THC is just one of ~150 cannabinoids in the plant and prohibition led to a genetic bottleneck for High THC chemotypes as cannabis was prosecuted on weight. 20% THC lines were bred that had 100x lower concentration of the alternative cannabinoids. This came at the expense of selection against the other cannabinoids as they all compete for the same precursors.
This is really evident now that the genomic architecture of the cannabinoid synthases have all been charted out.
The 2018 farm bill enabled genome directed breeding and the field has now bread CBD dominant chemotypes, CBG, CBDV, and THCV, so we are just getting these compounds in economical quantities for experimentation in many neuroinflammation based etiologies.
Some of these chemotypes were also bred prior to the with HPLC directed breeding but they are now getting enhanced with triploids and a variety of tools that were harder to industrialize prior to the change on legislation.
There are many interesting compounds for inflammation, IL-6 suppression and SEB/MISC recovery.
Google THC and SEB , you’ll find many papers from Mohammad et al.